First infusion in Houston for new Alzheimer’s drug administered at UTHealth Houston
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease. The recipient was 79-year-old Terrie Frankel. “We’re making history today,” Frankel said. Frankel began experiencing memory loss…
Pages